Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs.
Rocco CapuanoLuca ProsperiniManuela AltieriLorena LoreficeRoberta FantozziPaola CavallaClara GuaschinoMarta RadaelliCinzia CordioliViviana NocitiLaura BoffaPaolo RagoneseMaria Di GregorioFederica PinardiValentina Torri ClericiGiovanna De LucaAlberto GajofattoDamiano PaolicelliCarla TortorellaClaudio GasperiniClaudio SolaroEleonora CoccoAlvino BiseccoAntonio GalloPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Our results support the effectiveness of the third booster dose of mRNA-Vax against severe forms of COVID-19 in pwMS treated with OCR and FNG.